Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.5353
H.R.5353: Eliminating Opioid Related Infectious Diseases Act of 2018
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced March 20, 2018
- Latest Major Action June 13, 2018
Bill Sponsor
Bill Cosponsors
14 (7 Democrats, 7 Republicans)
Bill Versions
- Referred in Senate - June 13, 2018
- Engrossed in House - June 12, 2018
- Introduced in House - March 20, 2018
Bill Summary
Eliminating Opioid Related Infectious Diseases Act of 2018 This bill amends the Public Health Service Act to require the Centers for Disease Control and Prevention to expand its grant program for combating hepatitis C infections to include other infections associated with injection drug use.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Congressional Budget Office Estimate
Bill Actions
Date | Description |
---|---|
June 13, 2018 |
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
June 12, 2018 |
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
|
June 12, 2018 |
Considered under suspension of the rules.
|
June 12, 2018 |
Voice Vote in the HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5059) |
June 12, 2018 |
Considered under suspension of the rules. (consideration: CR H5059-5060)
|
June 12, 2018 |
Motion to reconsider laid on the table Agreed to without objection.
|
June 12, 2018 |
DEBATE - The House proceeded with forty minutes of debate on H.R. 5353.
|
June 12, 2018 |
Mr. Walden moved to suspend the rules and pass the bill, as amended.
|
May 9, 2018 |
Ordered to be Reported (Amended) by Voice Vote.
|
May 9, 2018 |
Committee Consideration and Mark-up Session Held.
|
April 25, 2018 |
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
|
April 25, 2018 |
Subcommittee Consideration and Mark-up Session Held.
|
April 25, 2018 |
Referred to the Subcommittee on Health.
|
March 20, 2018 |
Referred to the House Committee on Energy and Commerce.
|
March 20, 2018 |
Introduced in the House by Leonard Lance (R-N.J.) |